CNS Pharmaceuticals, Inc.
(NASDAQ: CNSP)

CNS Pharmaceuticals, Inc. is a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. Its product pipeline includes berubicin, and CNS-12. The company was founded by Waldemar Priebe in July 2017 and is headquartered in Houston, TX.

2.240 -

-0.035 (-1.54%)
Jarak 2.160 - 2.310   (6.94%)
Buka 2.310
Tutup Terdahulu 2.275
Harga Beli 2.170
Beli Purata 100
Jual Beli 2.240
Purata Jual 101
Purata 11,729
Nilai 12,155
Catatan -
Harga tertunda. Dikemas kini pada 03 Apr 2026 02:20.
Data dikuasakan oleh
Lihat Semua Acara


Loading Chart...

Please login to view stock data and analysis